Moody’s Advances Decision-Grade Credit Intelligence Across Enterprise AI Workflows, Powered by Microsoft 365 Copilot

 NEW YORK - 

Moody’s decision-grade intelligence now available directly in the AI-powered tools where market participants work

 

(BUSINESS WIRE)--Moody’s Corporation (NYSE: MCO) today announced the next phase of its strategic partnership with Microsoft, integrating Moody’s decision-grade intelligence directly into Microsoft AI solutions. The milestone expands the collaboration from co-innovation to scaled, workflow-embedded distribution of Moody’s decision-grade intelligence across the enterprise environments where its customers work every day.

“For over 115 years, Moody’s has served as the intelligence layer that financial professionals turn to when making consequential decisions,” said Rob Fauber, President and Chief Executive Officer of Moody’s. “By embedding that intelligence directly into Microsoft’s AI solutions at enterprise scale, we’re making decision-grade analysis available not just to specialists, but to every person across an organization who needs it.”

The integrations operate across two channels. Using the Model Context Protocol (MCP), Moody’s agentic workflows and decision‑grade intelligence are delivered through a dedicated Moody’s agent in Microsoft 365 Copilot, enabling organizations to activate Moody’s decision-grade intelligence without a need for custom integrations. In addition, Moody’s decision‑grade intelligence is available as a grounding data source across Microsoft 365 Copilot experiences, including Copilot Chat and Researcher agent, as well as through Copilot in Microsoft Excel, giving shared customers access to Moody’s credit ratings, research, entity data, and news as part of their research workflows.

"Our ongoing partnership with Moody's reflects a shared commitment to bring trusted financial intelligence directly into the tools professionals use every day,” said Bill Borden, Corporate Vice President, Worldwide Financial Services, Microsoft. “By integrating Moody's decision-grade insights into Microsoft 365 Copilot, we're making it easier for financial services professionals across the industry to access authoritative data and context in the flow of work - so they can move faster and act with confidence."

By embedding Moody’s credit intelligence into Microsoft’s AI solutions, the integration extends access beyond specialists to a broader set of users across institutions, supporting more consistent use of trusted credit context at every level of the enterprise. Moody’s connected intelligence – spanning 600 million entities, 2 billion ownership links, and major domains of risk – provides the trusted context layer that makes AI outputs valid, explainable, and auditable wherever they are delivered.

Moody’s AI partnerships reflect the company’s commitment to embedding its connected intelligence into the leading AI platforms where market participants are building and operating.

For more information, visit http://www.moodys.com/agenticsolutions.

About Moody’s Corporation

In a world shaped by increasingly interconnected risks, Moody's (NYSE: MCO) data, insights, and innovative technologies help customers develop a holistic view of their world and unlock opportunities. With a rich history of experience in global markets and a diverse workforce of approximately 16,000 across more than 40 countries, Moody's gives customers the comprehensive perspective needed to act with confidence and thrive. Learn more at moodys.com.

“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this document are forward-looking statements and are based on future expectations, plans and prospects for Moody’s business and operations that involve a number of risks and uncertainties. Such statements involve estimates, projections, goals, forecasts, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements. Stockholders and investors are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements and other information in this document are made as of the date hereof, and Moody’s undertakes no obligation (nor does it intend) to publicly supplement, update or revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise, except as required by applicable law or regulation. Factors, risks and uncertainties as well as other risks and uncertainties that could cause Moody’s actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements are described in greater detail under “Risk Factors” in Part I, Item 1A of Moody’s annual report on Form 10-K for the year ended December 31, 2025, and in other filings made by the Company from time to time with the SEC or in materials incorporated herein or therein. Stockholders and investors are cautioned that the occurrence of any of these factors, risks and uncertainties may cause the Company’s actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements, which could have a material and adverse effect on the Company’s business, results of operations and financial condition.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421137955/en/

Permalink

https://www.aetoswire.com/en/news/2104202654456

Contacts

For Moody’s Communications:

Joe Mielenhausen

Moody’s Corporation

+1 212-553-1461

Joe.Mielenhausen@moodys.com

Barnes Molding Solutions Becomes SPECTRIX

 (BUSINESS WIRE)--Barnes Molding Solutions is now SPECTRIX. The new Brand offers the full Spectrum of injection molding capabilities delivered by its leading brands - Männer, Foboha, Synventive, Priamus, Thermoplay, and Gammaflux. The change, announced at Chinaplas 2026, reflects the integration of core technologies within a single organization: part design, material science, hot runner and mold technology, sensors & controls and injection molding. Day-to-day operations remain unchanged, including contacts, contracts, and processes.

Focused on global growth

Under President Marcello Vendemiati, SPECTRIX is strengthening its global market focus and expanding its footprint. This strategy is already visible with the opening of a new manufacturing facility in Pune, India. Another production site near Detroit, USA, is set to open soon.

The name SPECTRIX combines “spectrum” and “plastics,” while reflecting the company’s core strengths: expertise, experience, and excellence. Its tagline, “Enduring Advantage, Engineered,” underscores the goal: delivering sustainable customer value along the full value chain by advanced engineering.

Expanded manufacturing services

SPECTRIX offers OEMs and high-volume manufacturers a fully integrated, end-to-end value chain from part design to global injection molding production. For highly complex applications, the company now also provides access to its own manufacturing capacity. This allows customers to leverage advanced technologies such as cube molds as production solutions under one roof.

New name, strong commitment

Previously part of the Barnes Group, the Molding Solutions business has been repositioned following Apollo’s reorganization into separate aerospace and industrial segments. The former Molding Solutions group now operates as SPECTRIX within the industrial segment. Dedicated leadership and structures enable greater flexibility and customer-specific value creation.

“While our name and identity are changing to SPECTRIX, our commitment remains the same: precision, reliability, and sustainable performance,” said Marcello Vendemiati, President of SPECTRIX.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260420154984/en/

Permalink

https://www.aetoswire.com/en/news/2104202654447

Contacts

press-communication@onebarnes.com

Andersen Global Strengthens West Africa Platform with the Addition of Member Firm in Ghana

 SAN FRANCISCO - Tuesday, 21. April 2026

(BUSINESS WIRE) -- Andersen Global continues its expansion across Africa, with Lima Partners joining as a member firm and introducing the Andersen name in Ghana.

Established in 2014 and headquartered in Accra, Andersen in Ghana is led by Managing Partner Daniel Addo Okoe. The firm provides a full range of professional services, including tax advisory, regulatory compliance, accounting and advisory, transfer pricing, payroll administration, immigration, and company secretarial services to both local and international clients operating in Ghana and the wider West African region.

“Becoming a member firm of Andersen Global marks a significant milestone for our organization,” said Kwame Amporful, senior partner of Andersen in Ghana. “Our clients will benefit from enhanced cross-border capabilities while continuing to receive practical, high-quality advisory services tailored to the Ghanaian market.”

“Ghana plays a vital role in facilitating cross-border trade and investment within West Africa,” added Mark L. Vorsatz, Global Chairman and CEO of Andersen. “The establishment of Andersen in Ghana represents an important step toward building a seamless and fully integrated platform across the region.”

Andersen Global is an international association of legally separate, independent member firms comprising tax, legal, and valuation professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421157121/en/

Permalink

https://www.aetoswire.com/en/news/2104202654459

Contacts

Megan Tsuei

Andersen Global

415-764-2700

The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible

 (BUSINESS WIRE) -- The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable Energy Supply – uses Germany, where 60 percent of electricity is already generated by renewable sources – as an example to demonstrate the supply security of a renewable energy system in leading industrial nations. More than 2,800 exhibitors and over 100,000 visitors from all over the world are expected to attend Europe’s largest alliance of exhibitions for the energy industry.

Interested visitors can immerse themselves in the special exhibit’s four thematic areas: industry, commerce, residential applications and mobility. In each area you can experience how power generation, storage, flexibilization and digitalization work together. While wind and solar are volatile and do not provide a constant power supply, solutions and technologies are already available today that allow companies, utilities, and consumers to manage fluctuations and surplus generation. “Electricity from solar and wind is already unbeatably cheap. The energy transition is unstoppable and delaying it will only damage the economy. Companies can reduce their energy costs long term and ensure competitiveness through renewable energy. Secure supply is guaranteed through flexibilization, the combination of intelligent storage, digital grid solutions and sector coupling,” says Markus Elsässer, Founder and CEO of Solar Promotion GmbH.

The energy system of the future

The key to transforming the energy supply is the electrification of all areas – from transportation and heat generation to industry. Electrification will act as a driver for innovation and economic growth. This, in turn, will increase added value, much more than through imported crude oil and gas. “With the special exhibit, we will highlight the right topics at the right time, showing that the energy transition is not only possible, but also makes sense from an economic, political and social point of view. It is down to us to seize this opportunity,” says Jens Mohrmann, CEO of Freiburg Wirtschaft Touristik und Messe GmbH & Co. KG (FWTM). The special exhibit will be accompanied by live demos, discussions and expert presentations that will highlight the opportunities and challenges of the renewable energy system.

As Europe’s largest alliance of exhibitions for the energy industry, The smarter E Europe unites four exhibitions (Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe) and will take place at Messe München from June 23–25, 2026.

For more information, please visit: www.TheSmarterE.de

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421244001/en/

Permalink

https://www.aetoswire.com/en/news/2104202654455

Contacts

Solar Promotion GmbH | P.O. Box 100 170 | 75101 Pforzheim

Horst Dufner | Tel.: +49 7231 58598-0 | Fax: +49 7231 58598-28

dufner@solarpromotion.de

Press contact:

RYSM | Schlesische Straße 26/c4 |10997 Berlin

Roberto Freiberger | Tel.: +49 163 8430 943

roberto.freiberger@rysm.com

Solar Promotion GmbH | P.O. Box 100 170 | 75101 Pforzheim

Peggy Härter-Zilay | Tel.: +49 7231 58598-240

haerter-zilay@solarpromotion.com

 

Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

 LEXINGTON, Mass. & MARLOW, England - Tuesday, 21. April 2026 AETOSWire Print 

Partnership enables timely access to botensilimab plus balstilimab through France’s government-reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named-patient programs (NPP) in select countries

 

 

(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and BAP Pharma, a global medicines access and clinical trial supply company, today announced the exclusive appointment of BAP Pharma as Agenus’ global partner for botensilimab (BOT) plus balstilimab (BAL) authorized global access programs.

The partnership supports compliant, patient-focused access to BOT+BAL through authorized pathways where permitted by local regulations. Effective immediately, BAP Pharma will serve as Agenus’ exclusive partner for the coordination of BOT+BAL global access program operations, including program requests, case coordination, distribution logistics, and related payment processing.

These programs include France’s Autorisation d’Accès Compassionnel (AAC) pathway as well as paid named-patient programs (NPPs) in select countries outside the United States. As previously disclosed, Agenus has received more than 270 physician inquiries from more than 30 countries across these pathways.

“Physicians around the world continue to express strong interest in BOT+BAL through authorized early access pathways, informed by the growing body of clinical data generated to date and the urgent need for better options for patients with serious cancers,” said Garo H. Armen, PhD, Chairman and CEO of Agenus. “Our exclusive partnership with BAP Pharma strengthens the infrastructure behind these programs and reinforces our commitment to act responsibly and efficiently. Where access is permitted, we believe we have a moral responsibility to help enable appropriate, compliant access for patients whose physicians are seeking new alternatives.”

France’s AAC program provides hospital-based, fully government-reimbursed access to BOT+BAL for eligible patients with MSS metastatic colorectal cancer without active liver metastases, platinum-resistant or platinum-refractory ovarian cancer, and certain advanced soft-tissue sarcomas under a nationally defined protocol. These patients typically have advanced cancers for which standard treatment options have been exhausted. Outside France, BOT+BAL may be available in select countries through paid NPPs initiated by treating physicians and governed by local regulations, including where a treating physician determines that BOT+BAL is an appropriate option for an individual patient based on the clinical data generated to date, medical need, and applicable local requirements.

Physician interest in BOT+BAL access has broadened across regions. Patients have already been treated through regulatory-authorized paid named-patient programs in multiple countries across South and Central America and Europe, including the United Kingdom, Switzerland, Greece, Brazil, and Argentina, with expansion into Spain where permitted by local regulations.

Under the collaboration, BAP Pharma will coordinate Agenus’ global access operations across these programs. BAP Pharma brings extensive global medicines access experience, a professional and responsive approach to physician and site engagement, and the operational rigor required to streamline logistics, strengthen regional coordination, and support treating physicians navigating country-specific regulatory frameworks.

“BAP Pharma’s team has demonstrated the professionalism, responsiveness, and operational rigor that are essential in supporting global access programs,” said Kamel Djazouli, M.D., Head of Medical Affairs of Agenus. “Their approach aligns well with our commitment to physicians and patients seeking access through authorized pathways, and we believe this partnership will help strengthen the experience for health care teams around the world.”

Bashir Parkar, M.D., Founder of BAP Pharma, commented, “Being selected as Agenus’ exclusive global partner is a significant milestone for BAP Pharma. It reflects the trust placed in our ability to deliver compliant, patient-focused access solutions at scale. Our role is to remove complexity and ensure physicians can access critical therapies for their patients with confidence, speed, and full regulatory alignment.”

Rebecca Bibby, Group Director, Medicines Access at BAP Pharma, added, “This partnership demonstrates the growing importance of well-structured global access programs in today’s clinical and regulatory environment. By combining Agenus’ innovative therapies with BAP Pharma’s global operational expertise, we are enabling a more seamless, reliable pathway for physicians and patients navigating early access options.”

Agenus’ early access efforts complement its ongoing clinical development strategy for BOT+BAL, including the global Phase 3 BATTMAN trial in refractory MSS/pMMR metastatic colorectal cancer. Until marketing authorization is granted, BOT+BAL is available only through clinical trials and authorized access pathways where permitted and available under local regulatory frameworks. Visit Agenus’ website for more information on patient access at Access to Investigational Medicines Policy.

About Agenus

Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants. Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.

About Botensilimab (BOT)

Botensilimab (BOT) is a human Fc enhanced multifunctional anti-CTLA-4 antibody designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action to extend immunotherapy benefits to “cold” tumors which generally respond poorly to standard of care or are refractory to conventional PD-1/CTLA-4 therapies and investigational therapies. Botensilimab augments immune responses across a wide range of tumor types by priming and activating T cells, downregulating intratumoral regulatory T cells, activating myeloid cells and inducing long-term memory responses.

Approximately 1,200 patients have been treated with botensilimab and/or balstilimab in phase 1 and phase 2 clinical trials. Botensilimab alone, or in combination with Agenus’ investigational PD-1 antibody, balstilimab, has shown clinical responses across nine metastatic, late-line cancers. For more information about botensilimab trials, visit www.clinicaltrials.gov.

About Balstilimab (BAL)

Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been evaluated in more than 900 patients to date and has demonstrated clinical activity and a favorable tolerability profile in several tumor types.

About BAP Pharma

BAP Pharma is a global partner to the pharmaceutical and biotech industry, delivering clinical trial supply and medicines access solutions. Its core focus is Medicines Access, enabling timely, compliant access to critical therapies through early and managed access programmes worldwide. Across its services, BAP Pharma aims to deliver certainty—removing complexity and ensuring confidence for sponsors, physicians, and patients.

Website: https://bappharma.com/

LinkedIn: https://linkedin.com/company/bap-pharma

Forward-Looking Statements

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding its botensilimab and balstilimab programs, expected regulatory timelines and filings, and any other statements containing the words "may," "believes," "expects," "anticipates," "hopes," "intends," "plans," "forecasts," "estimates," "will," “establish,” “potential,” “superiority,” “best in class,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the factors described under the Risk Factors section of our most recent Annual Report on Form 10-K for 2025, and subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and Agenus undertakes no obligation to update or revise the statements, other than to the extent required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Source: Agenus Inc. & BAP Pharma

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421146539/en/

Permalink

https://www.aetoswire.com/en/news/54519143

Contacts

 

Agenus Investors: 917-362-1370 | investor@agenusbio.com

Agenus Media: 781-674-4422 | communications@agenusbio.com

BAP Pharma Media: Jason De Kauwe | Jason.DeKauwe@bappharma.com

GasEntec to Deliver Landmark Dakar LNG Terminal Supporting Senegal’s Energy Transition

 ELTON Logistics & Services’ jetty-based LNG regasification terminal to become West Africa’s flagship LNG import facility.

(BUSINESS WIRE) -- GasEntec, the global LNG technology and assets company, along with affiliates, has announced today that it has entered into contracts with ELTON Logistics & Services to deliver a jetty-based LNG regasification unit (JRU) and associated onshore LNG equipment for the Dakar LNG Terminal in Dakar, Senegal.

The new LNG terminal will become West Africa’s flagship LNG import facility, supplying natural gas to a 300MW combined-cycle power plant in Cap des Biches, Dakar – Senegal’s largest power plant – as well as several other power plants, industrial customers, and various additional users. The project supports Senegal’s continued energy transition as the country diversifies its fuel sources while enabling economic and industrial growth.

The project was awarded under a mandate to address urgent national power-sector requirements. GasEntec expects first gas on an expedited basis, with full terminal operations targeted for the first half of 2027.

“This terminal represents a momentous step in strengthening Senegal’s energy security and supporting the nation’s accelerating industrial growth,” said Babacar Tall, CEO of ELTON Logistics & Services. “We are thrilled to work with GasEntec, which brings its global credentials in LNG regasification technology and development.”

Arieh Mimran, Chairman of GasEntec, said, “We are honored to support Senegal’s energy transition. The Dakar LNG Terminal symbolizes an unprecedented effort toward the country's rapid development. It is a privilege to oversee GasEntec as it provides critical assets for this great nation's sovereignty.”

Joongin Ko, Chief Project Officer at GasEntec, added, “ELTON Logistics & Services’ use of GasEntec’s proprietary technology and modular approach to downstream LNG at the Dakar LNG Terminal highlights our flexible and fast deployment along with our ability to meet the most exacting parameters.”

Founded in South Korea, GasEntec has delivered major LNG infrastructure across Asia, Africa, the Middle East, Europe, and the Americas, serving sovereign, utility, and industrial clients.

About GasEntec

GasEntec is an energy technology platform delivering fast, modular LNG infrastructure essential to meet accelerating global demand for digital infrastructure, AI expansion, flexible baseload fuels, and sovereign energy security.

Its dual-engine model combines a technology business built on credentialed modular LNG intellectual property with a scalable asset platform that sells, leases, or charters integrated LNG solutions.

GasEntec’s modular floating and onshore LNG systems enable rapid, scalable deployment of downstream LNG infrastructure, providing clients with integrated solutions to distribute LNG to and within critical markets.

Founded in 2006 in South Korea, GasEntec has become a key provider of modular LNG infrastructure and equipment supporting global LNG logistics and regasification.

About ELTON Logistics & Services

ELTON Logistics and Services is a West African energy infrastructure company based in Dakar, Senegal. The company is a wholly owned subsidiary of ELTON Oil Company, Senegal’s leading fuel distribution company, which has played a key role over the past 26 years in supplying oil products for power generation. ELTON Oil Company also operates in Guinea-Conakry, Guinea-Bissau, Mauritania, and Côte d’Ivoire.

For more information, please visit www.gasentec.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421503002/en/

Permalink

https://aetoswire.com/en/news/2104202654451

Contacts

Steve Olson

Chief Marketing Officer

steveo@gasentec.com

+1 (770) 710-4768

Montieth & Company

gasentec@montiethco.com

BRIDGE Alliance étend son sommet à cinq jours dans le cadre de l’expansion de sa plateforme mondiale des médias

 

ABU DHABI, United Arab Emirates, - lundi, 20. avril 2026

BRIDGE Alliance annonce une nouvelle envergure à son sommet phare, le BRIDGE Summit, qui s’étendra sur cinq jours pour sa deuxième édition, du 28 novembre au 2 décembre 2026. L’événement prendra également place dans un cadre plus vaste et emblématique, Yas Island à Abou Dhabi, en partenariat avec Miral, leader dans la création de destinations et d’expériences immersives au sein de l’Émirat.

Cette évolution stratégique majeure traduit l’ambition de BRIDGE de s’imposer comme une plateforme mondiale de référence, active tout au long de l’année. Elle vise à jouer un rôle déterminant dans la transformation du paysage médiatique, le développement de l’économie créative et le renforcement des collaborations transfrontalières.

L’annonce a été faite lors de la troisième réunion du conseil d’administration, présidée par Son Excellence Cheikh Abdulla bin Mohammed bin Butti Al Hamed, au cours de laquelle les membres ont présenté des plans visant à faire évoluer BRIDGE, d’un rassemblement à fort impact, vers une plateforme institutionnelle plus pérenne, conçue pour impulser une transformation durable du secteur.

Le BRIDGE Summit 2026 réunira des leaders issus des médias, des technologies, de l’investissement et de la création de contenu, avec pour objectif de renforcer l’engagement professionnel. Il s’agira notamment de favoriser l’émergence de nouveaux modèles économiques, de stimuler la coproduction et de faciliter l’accès aux marchés régionaux et internationaux.

« BRIDGE est un projet institutionnel de long terme qui redéfinit en profondeur le rôle des médias dans l’équation du développement, de l’économie et du savoir », affirme Son Excellence Cheikh Abdulla Al Hamed.

La programmation continuera de s’articuler autour de sept secteurs stratégiques — médias, économie des créateurs, technologies et intelligence artificielle, marketing, gaming, musique et cinéma — autant de forces motrices qui transforment en profondeur l’écosystème mondial du contenu. L’allongement de la durée du sommet, conjugué au choix d’un site d’envergure accrue, illustre une demande internationale croissante pour des plateformes capables de dépasser le simple échange d’idées, au profit de résultats tangibles, mesurables et à fort impact.

Son Excellence Dr Jamal Al Kaabi, Vice-président de BRIDGE Alliance, ajoute : « Le BRIDGE Summit incarne la transition stratégique des Émirats arabes unis, qui passent d’un rôle de soutien à l’économie des médias à celui d’architecte et d’opérateur de ses plateformes ».

La première édition du BRIDGE Summit, organisée en décembre 2025 à l’ADNEC, a connu un succès remarquable en rassemblant plus de 40 000 participants venus de 182 pays. Elle a également donné lieu à 1 276 réunions d’affaires et à la conclusion de 48 accords et partenariats stratégiques, posant ainsi des bases solides et structurantes pour son développement et son expansion à l’échelle internationale.

À propos de BRIDGE Alliance
BRIDGE Alliance est une organisation mondiale indépendante, dont le siège est basé à Abou Dhabi, dédiée à la promotion de la collaboration, de la confiance et de l’innovation à travers l’écosystème médiatique international.Des photos accompagnant cette annonce sont disponibles via les liens suivants :
https://www.globenewswire.com/NewsRoom/AttachmentNg/30815fbe-abb3-4df1-a38d-c5fc572115cc
https://www.globenewswire.com/NewsRoom/AttachmentNg/4a5bbaef-558b-4b55-947f-749ee99b2d52

Contacts :

Contact: Kholood Albuainain, Executive.Office@bridge-summit.com